Table 1.
Association between IL-33 expression and clinicopathological features
Characteristic | IL-33 high | IL-33 low | Total | χ 2 | P value |
---|---|---|---|---|---|
Gender | |||||
Male | 31 | 33 | 64 | 1.063 | 0.303 |
Female | 3 | 1 | 4 | ||
Age | |||||
< 60 | 20 | 12 | 32 | 3.778 | 0.052 |
≥ 60 | 14 | 22 | 36 | ||
Tumor grade | |||||
T1–2 | 20 | 29 | 49 | 5.916 | 0.015* |
T3–4 | 14 | 5 | 19 | ||
Tumor differentiation | |||||
High | 12 | 14 | 26 | 3.324 | 0.190 |
Medium | 9 | 11 | 22 | ||
Low | 14 | 6 | 20 | ||
Lymph node metastasis | |||||
No | 24 | 33 | 57 | 8.785 | 0.003** |
Yes | 10 | 1 | 11 | ||
AJCC TNM stage | |||||
I–II | 18 | 29 | 47 | 8.336 | 0.004** |
III–IV | 16 | 5 | 21 |
*P < 0.05 and **P < 0.01